Compare NSRX & LPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSRX | LPSN |
|---|---|---|
| Founded | 2019 | 1995 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.5M | 47.0M |
| IPO Year | N/A | 2000 |
| Metric | NSRX | LPSN |
|---|---|---|
| Price | $5.06 | $2.83 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $20.50 | N/A |
| AVG Volume (30 Days) | 2.3K | ★ 117.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $249,838,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.90 | $0.39 |
| 52 Week High | $9.99 | $7.54 |
| Indicator | NSRX | LPSN |
|---|---|---|
| Relative Strength Index (RSI) | 44.19 | 37.62 |
| Support Level | N/A | $2.56 |
| Resistance Level | $6.39 | $4.23 |
| Average True Range (ATR) | 0.74 | 0.20 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 30.57 | 32.26 |
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.